Showing 1961-1970 of 2050 results for "".
- MicroSurgical Technology Releases MST 19-Gauge Ahmed Micro Stent Cutterhttps://modernod.com/news/microsurgical-technology-releases-mst-19-gauge-ahmed-micro-stent-cutter/2476768/To address challenging microstent revision surgery, MicroSurgical Technology (MST), in collaboration with glaucoma and cataract surgeon Ike Ahmed, MD, has developed the MST 19-gauge Ahmed Micro Stent Cutter. Bringing precision and control, the new instrument enables an efficient and minimally inv
- Market Scope: Advancing Technology Drives Ophthalmic OR Microscope Market to 6 Percent Growth by 2024https://modernod.com/news/market-scope-advancing-technology-drives-ophthalmic-or-microscope/2476746/Manufacturers continue to push the envelope integrating advanced technology into the surgical suite with their top-of-the-line ophthalmic OR microscopes, bringing 4K and 3-D heads-up display with integrated diagnostics—for those who can afford the price tag. Market Scope expects the global
- Medicel Launches First 2-in-1 Lens Injection Systemhttps://modernod.com/news/medicel-launches-first-2-in-1-lens-injection-system/2476740/Medicel says it has launched the world’s first 100% 2-in-1 lens injector, the Accuject Dual. The new injector enables surgeons to operate either in push or screw mode, allowing more control. Unlike competitor dual-mode injectors on the market that are 50% push and 50% screw, the Accuject
- American Academy of Optometry Announces 2019 Award Recipientshttps://modernod.com/news/american-academy-of-optometry-announces-2019-award-recipients/2476738/The American Academy of Optometry announced its 2019 award recipients, recognizing distinguished individuals who have made important contributions to advancing the profession of optometry: Raymond A. Applegate,
- EKF Quo-Test Supports Improved Medical Management of Diabetic Retinopathy Patientshttps://modernod.com/news/ekf-quo-test-supports-improved-medical-management-of-diabetic-retinopathy-patients/2476736/EKF Diagnostics announced that its Quo-Test HbA1c analyzer is supporting improved medical management of patients with sight-threatening diabetic retinopathy (DR). The effectiveness of this point-of-care HbA1c testing application for rapid assessment of glycaemic control in eye clinic patients has
- Market Scope: Booming Demand, Surgical Planning Integration Drive Growth in Ophthalmic Diagnostic Markethttps://modernod.com/news/market-scope-booming-demand-surgical-planning-integration-drive-growth-in-ophthalmic-diagnostic-market/2476723/Market Scope estimates that the ophthalmic diagnostic equipment market will total $3.2 billion in 2019, and the firm expects it to increase to $3.8 billion in 2024—for a compound annual growth rate of 3.9 percent. Contributing factors include a rising global population, with an expanding elderly
- AlpineInvestors to Make Strategic Growth Investments in Ohio Eye Care Businesseshttps://modernod.com/news/alpineinvestors-to-make-strategic-growth-investments-in-ohio-eye-care-businesses/2476694/Private equity firm Alpine Investors has invested in Ohio-based eye care business, Northeast Ohio Eye Surgeons (NEOES), including its subsidiary business, Ohio Eye Care Consultants (OECC). The two companies will together form a new ophthalmology platform for Alpine, and will continue to operate i
- Outdoor Exercise Reduces Progression of Common Vision Issue in Childrenhttps://modernod.com/news/outdoor-exercise-reduces-progression-of-common-vision-issue-in-children/2476693/New research suggests that adding 30 minutes of daily outdoor activity reduces the progression of myopia in children if the activity is continued. The study, conducted by researchers in Beijing, China, is published in
- Dompé Announces First Patient Enrolled in Phase 2b Clinical Trial Investigating Dry Eye Disease Drug Candidatehttps://modernod.com/news/dompe-announces-first-patient-enrolled-in-phase-2b-clinical-trial-investigating-dry-eye-disease-drug-candidate/2476687/Dompé Farmaceutici S.p.A and Dompé U.S. announced that the first patient has been enrolled in NGF0118, a multicenter, randomized, double-masked, vehicle-controlled, parallel group study to evaluate the safety and efficacy of rhNGF eye solution vs. vehicle in patients with moderate to severe dry e
- CooperVision Showcases Latest Research in Series of Poster Sessions at Optometry’s Meeting 2019https://modernod.com/news/coopervision-showcases-latest-research-in-series-of-poster-sessions-at-optometrys-meeting-2019/2476676/As part of its commitment to the continuous advancement of contact lens study and support, CooperVision will share the results of new research in a series of four poster sessions at Optometry’s Meeting 2019 in St. Louis. The posters examine the performance of CooperVision clariti 1 day multifocal